沙特专家共识:急性哮喘与慢阻肺急性加重的急诊管理及雾化给药装置推荐算法
该共识由8名肺科、急诊科和呼吸治疗专家(含SASEM及SINA、沙特COPD指南作者)采用改良Delphi流程制定,2025年11月19日在利雅得召开顾问委员会会议,围绕10个预设临床问题讨论并对2项装置选择声明正式投票。共识采用双阶段严重度分类:急诊快速分诊用「非重度 vs 重度」二分模型,临床管理用SINA四级分类;药物治疗算法标准化,优先早期糖皮质激素并优化支气管扩张剂剂量以减少毒性。专家组一致认为雾化给药装置选择显著影响治疗成功,A-VMN按严重程度以递增推荐强度(IIb至I类)推荐,重症和通气患者为首选,依据为肺沉积更优、感染控制优势和出院率改善。
要点
- 急诊快速分诊采用「非重度 vs 重度」二分模型,随后按SINA四级分类进行临床管理。
- 药物治疗算法标准化,优先早期糖皮质激素治疗,并优化支气管扩张剂剂量以减轻毒性。
- 专家组一致认为雾化给药装置选择显著影响治疗成功。
- A-VMN按严重程度以递增推荐强度(IIb至I类)推荐,重症和通气患者为首选。
- A-VMN获推荐依据为肺沉积更优、感染控制优势和出院率改善。
适用人群与场景
- 沙特阿拉伯急诊科就诊的急性哮喘和慢性阻塞性肺疾病(COPD)急性加重患者。
诊断标准与关键阈值
- 双阶段严重度分类:急诊快速分诊采用「非重度 vs 重度」二分模型,随后采用SINA四级分类进行临床管理。
处置流程与药物剂量
- 药物治疗算法标准化,优先早期糖皮质激素治疗。
- 优化支气管扩张剂剂量以减轻毒性。
- A-VMN按严重程度以递增推荐强度(IIb至I类)推荐,重症和通气患者为首选选项。
研究设计与关键结果
- 采用改良专家共识流程并结合Delphi要素,8名多学科专家(肺科、急诊科、呼吸治疗)参与,其中3名隶属沙特急诊医学会(SASEM)、2名为SINA指南作者、3名为沙特COPD指南作者。
- 顾问委员会会议于2025年11月19日在利雅得举行,作为正式共识轮次,涵盖两场主持辩论中的10个预设临床问题,并对2项关键装置选择声明进行正式投票。
- 专家组一致认为雾化给药装置选择显著影响治疗成功。
- A-VMN按严重程度以递增推荐强度(IIb至I类)推荐,重症和通气患者为首选,依据为肺沉积更优、感染控制优势和出院率改善。
证据类型、等级与局限
- 证据类型:改良专家共识(含Delphi要素)。
对床旁实践的改变
- 急诊对急性哮喘和COPD急性加重可先以「非重度 vs 重度」二分法快速分诊,再按SINA四级分类管理。
- 药物治疗算法优先早期糖皮质激素并优化支气管扩张剂剂量以减少毒性。
- 选择雾化给药装置时,A-VMN按严重程度以IIb至I类递增强度推荐,重症和通气患者为首选。
指南或共识出处
- 沙特专家共识:急性哮喘与COPD急性加重的管理及雾化给药装置推荐算法,发表于International Journal of Emergency Medicine。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「红旗征与不能漏的情况」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
OBJECTIVE: To develop a practical, expert consensus for the management of acute asthma and chronic obstructive pulmonary disease (COPD) exacerbations in Saudi Arabia's Emergency Departments (EDs), addressing gaps in triage, diagnostic certainty, and aerosol delivery.
METHODS: A modified expert consensus process with Delphi elements was employed. Eight multidisciplinary experts in pulmonary medicine, emergency medicine, and respiratory therapy, three of whom were affiliated with the Saudi Society of Emergency Medicine (SASEM), two of whom are authors of the Saudi initiative for Asthma (SINA) Guidelines, and three of whom are authors of the Saudi COPD guidelines, reviewed evidence-based presentations and formulated structured discussion questions before the meeting. The advisory board session (Riyadh, November 19, 2025) served as the formal consensus round, addressing ten predefined clinical questions across two moderated debate sessions, with formal voting on two key device-selection statements.
RESULTS: The panel adopted a dual-phase severity classification: a binary "Non-Severe vs. Severe" model for rapid ED triage, followed by the four-tier SINA classification for clinical management. Pharmacological algorithms were standardized, prioritizing early corticosteroid therapy and optimizing bronchodilator dosing to mitigate toxicity. The panel reached a unanimous consensus that aerosol delivery device selection significantly influences treatment success; A-VMN was recommended at escalating strengths across severity levels (Class IIb-I) and as a preferred option for severe and ventilated patients, based on superior lung deposition, infection control advantages, and improved discharge rates.
CONCLUSION: This modified expert consensus aims to provide an up-to-date, organized, and action-oriented protocol for Saudi EDs. It advocates a stratified triage system and evidence-based selection of aerosol-delivery devices to improve patient outcomes, enhance safety, and optimize resource utilization.
参考来源
- Al Aseri Z, Zeitouni M, Idrees M, et al. Saudi expert consensus on the management of acute asthma and COPD exacerbations with algorithm of aerosol drug delivery device recommendations. Int J Emerg Med. 2026. PMID: 42625150. doi:10.1186/s12245-026-01350-7
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。